Skip to main content
Top
Published in: BMC Infectious Diseases 1/2012

Open Access 01-12-2012 | Research article

Definition and characterization of localised meningitis epidemics in Burkina Faso: a longitudinal retrospective study

Authors: Haoua Tall, Stéphane Hugonnet, Philippe Donnen, Michèle Dramaix-Wilmet, Ludovic Kambou, Frank Drabo, Judith E Mueller

Published in: BMC Infectious Diseases | Issue 1/2012

Login to get access

Abstract

Background

The epidemiology of meningococcal meningitis in the African meningitis belt is characterised by seasonality, localised epidemics and epidemic waves. To facilitate research and surveillance, we aimed to develop a definition for localised epidemics to be used in real-time surveillance based on weekly case reports at the health centre level.

Methods

We used national routine surveillance data on suspected meningitis from January 2004 to December 2008 in six health districts in western and central Burkina Faso. We evaluated eight thresholds composed of weekly incidence rates at health centre level for their performance in predicting annual incidences of 0.4%and 0.8% in health centre areas. The eventually chosen definition was used to describe the spatiotemporal epidemiology and size of localised meningitis epidemics during the included district years.

Results

Among eight weekly thresholds evaluated, a weekly incidence rate of 75 cases per 100,000 inhabitants during at least two consecutive weeks with at least 5 cases per week had 100% sensitivity and 98% specificity for predicting an annual incidence of at least 0.8% in health centres. Using this definition, localised epidemics were identified in all but one years during 2004-2008, concerned less than 10% of the districts' population and often were geographically dispersed. Where sufficient laboratory data were available, localised epidemics were exclusively due to meningococci.

Conclusions

This definition of localised epidemics a the health centre level will be useful for risk factor and modelling studies to understand the meningitis belt phenomenon and help documenting vaccine impact against epidemic meningitis where no widespread laboratory surveillance exists for quantifying disease reduction after vaccination.
Appendix
Available only for authorised users
Literature
1.
go back to reference Stephens DS, Greenwood B, Brandtzaeg P: Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet. 2007, 369: 2196-2210. 10.1016/S0140-6736(07)61016-2.CrossRefPubMed Stephens DS, Greenwood B, Brandtzaeg P: Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet. 2007, 369: 2196-2210. 10.1016/S0140-6736(07)61016-2.CrossRefPubMed
2.
go back to reference Mueller JE, Borrow R, Gessner BD: Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines. Expert Rev Vaccines. 2006, 5: 3-CrossRef Mueller JE, Borrow R, Gessner BD: Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines. Expert Rev Vaccines. 2006, 5: 3-CrossRef
3.
go back to reference Collard JM, Maman Z, Yacouba H, Djibo S, Nicolas P, Jusot JF, Rocourt J, Maitournam R: Increase in Neisseria meningitidis Serogroup W135, Niger, 2010. Emerg Infect Dis. 2010, 16: 1496-1498.CrossRefPubMedPubMedCentral Collard JM, Maman Z, Yacouba H, Djibo S, Nicolas P, Jusot JF, Rocourt J, Maitournam R: Increase in Neisseria meningitidis Serogroup W135, Niger, 2010. Emerg Infect Dis. 2010, 16: 1496-1498.CrossRefPubMedPubMedCentral
4.
go back to reference Boisier P, Nicolas P, Djibo S, Taha MK, Jeanne I, Maïnassara HB, Tenebray B, Kairo KK, Giorgini D, Chanteau S: Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger. Clin Infect Dis. 2007, 44: 657-663. 10.1086/511646.CrossRefPubMed Boisier P, Nicolas P, Djibo S, Taha MK, Jeanne I, Maïnassara HB, Tenebray B, Kairo KK, Giorgini D, Chanteau S: Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger. Clin Infect Dis. 2007, 44: 657-663. 10.1086/511646.CrossRefPubMed
5.
go back to reference Delrieu I, Yaro S, Tamekloé TA, Njanpop-Lafourcade BM, Tall H, Jaillard P, Ouedraogo MS, Badziklou K, Sanou O, Drabo A, Gessner BD, Kambou JL, Mueller JE: Emergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina Faso. PLoS One. 2011, 6 (5): e19513-10.1371/journal.pone.0019513. Epub 2011 May 20CrossRefPubMedPubMedCentral Delrieu I, Yaro S, Tamekloé TA, Njanpop-Lafourcade BM, Tall H, Jaillard P, Ouedraogo MS, Badziklou K, Sanou O, Drabo A, Gessner BD, Kambou JL, Mueller JE: Emergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina Faso. PLoS One. 2011, 6 (5): e19513-10.1371/journal.pone.0019513. Epub 2011 May 20CrossRefPubMedPubMedCentral
6.
go back to reference World Health Organization: Detecting meningococcal meningitis epidemics in highly-endemic African countries. Weekly Epidemiological Record. 2000, 75: 305-312. World Health Organization: Detecting meningococcal meningitis epidemics in highly-endemic African countries. Weekly Epidemiological Record. 2000, 75: 305-312.
7.
go back to reference Lewis R, Nathan N, Diarra L, Belanger F, Paquet C: Timely detection of meningococcal meningitis epidemics in Africa. Lancet. 2001, 358: 287-293. 10.1016/S0140-6736(01)05484-8.CrossRefPubMed Lewis R, Nathan N, Diarra L, Belanger F, Paquet C: Timely detection of meningococcal meningitis epidemics in Africa. Lancet. 2001, 358: 287-293. 10.1016/S0140-6736(01)05484-8.CrossRefPubMed
8.
go back to reference World Health Organization: Enhanced surveillance of epidemic meningococcal meningitis in Africa: a three-year experience. Weekly Epidemiological Record. 2005, 80: 313-320. World Health Organization: Enhanced surveillance of epidemic meningococcal meningitis in Africa: a three-year experience. Weekly Epidemiological Record. 2005, 80: 313-320.
9.
go back to reference Thomson MC, Molesworth AM, Djingarey MH, Yameogo KR, Belanger F, Cuevas LE: Potential of environmental models to predict meningitis epidemics in Africa. Trop Med Internat Health. 2006, 11: 78781-78788.CrossRef Thomson MC, Molesworth AM, Djingarey MH, Yameogo KR, Belanger F, Cuevas LE: Potential of environmental models to predict meningitis epidemics in Africa. Trop Med Internat Health. 2006, 11: 78781-78788.CrossRef
10.
go back to reference Greenwood BM, Bradley AK, Cleland PG, Haggie MH, Hassan-King M, Lewis LS, Macfarlane JT, Taqi A, Whittle HC, Bradley-Moore AM, Ansari Q: An epidemic meningococcal infection at Zaria, Northern Nigeria. 1. General epidemiological features. Transact Royal Soc Trop Med Hygiene. 1979, 73: 557-562. 10.1016/0035-9203(79)90052-X.CrossRef Greenwood BM, Bradley AK, Cleland PG, Haggie MH, Hassan-King M, Lewis LS, Macfarlane JT, Taqi A, Whittle HC, Bradley-Moore AM, Ansari Q: An epidemic meningococcal infection at Zaria, Northern Nigeria. 1. General epidemiological features. Transact Royal Soc Trop Med Hygiene. 1979, 73: 557-562. 10.1016/0035-9203(79)90052-X.CrossRef
11.
go back to reference Sié A, Pflüger V, Coulibaly B, Dangy JP, Kapaun A, Junghanss T, Pluschke G, Leimkugel J: ST-2859 serogroup A meningococcal meningitis outbreak in Nouna Health District, Burkina Faso: a prospective study. Trop Med Internat Health. 2008, 13: 861-868. 10.1111/j.1365-3156.2008.02056.x.CrossRef Sié A, Pflüger V, Coulibaly B, Dangy JP, Kapaun A, Junghanss T, Pluschke G, Leimkugel J: ST-2859 serogroup A meningococcal meningitis outbreak in Nouna Health District, Burkina Faso: a prospective study. Trop Med Internat Health. 2008, 13: 861-868. 10.1111/j.1365-3156.2008.02056.x.CrossRef
12.
go back to reference Mueller JE, Yaro S, Njanpop-Lafourcade BM, Drabo A, Idohou RS, Kroman SS, Sanou O, Diagbouga S, Traoré Y, Sangaré L, Borrow R, Gessner BD: Study of a localized meningococcal meningitis epidemic in Burkina Faso: incidence, carriage and immunity. J Infect Dis. 2011, 204: 1787-1795. 10.1093/infdis/jir623.CrossRefPubMedPubMedCentral Mueller JE, Yaro S, Njanpop-Lafourcade BM, Drabo A, Idohou RS, Kroman SS, Sanou O, Diagbouga S, Traoré Y, Sangaré L, Borrow R, Gessner BD: Study of a localized meningococcal meningitis epidemic in Burkina Faso: incidence, carriage and immunity. J Infect Dis. 2011, 204: 1787-1795. 10.1093/infdis/jir623.CrossRefPubMedPubMedCentral
13.
go back to reference Mueller JE, Gessner BD: A hypothetical explanatory model for meningococcal meningitis in the African meningitis belt. Int J Infect Dis. 2010, 15: 553-559.CrossRef Mueller JE, Gessner BD: A hypothetical explanatory model for meningococcal meningitis in the African meningitis belt. Int J Infect Dis. 2010, 15: 553-559.CrossRef
14.
go back to reference Traore Y, Tamekloe TA, Njanpop-Lafourcade BM, Lourd M, Yaro S, Niamba D, Drabo A, Mueller JE, Koeck JL, Gessner BD: Pneumococcal meningitis in Burkina Faso and Togo is common, seasonal, affects all age groups, and is highly lethal. Clin Infect Dis. 2009, 48: S181-189. 10.1086/596498.CrossRefPubMed Traore Y, Tamekloe TA, Njanpop-Lafourcade BM, Lourd M, Yaro S, Niamba D, Drabo A, Mueller JE, Koeck JL, Gessner BD: Pneumococcal meningitis in Burkina Faso and Togo is common, seasonal, affects all age groups, and is highly lethal. Clin Infect Dis. 2009, 48: S181-189. 10.1086/596498.CrossRefPubMed
18.
go back to reference Leake JAD, Kone ML, Yada A, Barry LF, Traore G, Ware A, Coulibaly T, Berthe A, Mambu Ma Disu H, Rosenstein NE, Plikaytis BD, Esteves K, Kawamata J, Wenger JD, Heymann DL, Perkins BA: Early detection and response to meningococcal disease epidemics in sub-Saharan Africa: appraisal of the WHO strategy. Bull WHO. 2002, 80: 342-349.PubMedPubMedCentral Leake JAD, Kone ML, Yada A, Barry LF, Traore G, Ware A, Coulibaly T, Berthe A, Mambu Ma Disu H, Rosenstein NE, Plikaytis BD, Esteves K, Kawamata J, Wenger JD, Heymann DL, Perkins BA: Early detection and response to meningococcal disease epidemics in sub-Saharan Africa: appraisal of the WHO strategy. Bull WHO. 2002, 80: 342-349.PubMedPubMedCentral
19.
go back to reference Moore PS: Meningococcal meningitis in sub-Saharan Africa: a model for the epidemic process. Clin Infect Dis. 1992, 14: 515-525. 10.1093/clinids/14.2.515.CrossRefPubMed Moore PS: Meningococcal meningitis in sub-Saharan Africa: a model for the epidemic process. Clin Infect Dis. 1992, 14: 515-525. 10.1093/clinids/14.2.515.CrossRefPubMed
20.
go back to reference Sultan B, Labadi K, Guégan JF, Fanicot S: Climate drives the meningitis epidemics onset in West Africa. PLoS Medicine. 2005, 2: 43-49. 10.1371/journal.pmed.0020043.CrossRef Sultan B, Labadi K, Guégan JF, Fanicot S: Climate drives the meningitis epidemics onset in West Africa. PLoS Medicine. 2005, 2: 43-49. 10.1371/journal.pmed.0020043.CrossRef
21.
go back to reference World Health Organization: Risk of epidemic meningitis in Africa: a cause for concern. Weekly Epidemiological Record. 2007, 10: 79-87. World Health Organization: Risk of epidemic meningitis in Africa: a cause for concern. Weekly Epidemiological Record. 2007, 10: 79-87.
22.
go back to reference Parent du Châtelet I, Traore Y, Gessner BD, Antignac A, Naccro B, Njanpop-Lafourcade BM, Ouedraogo MS, Tiendrebeogo SR, Varon E, Taha MK: Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing. Clin Infect Dis. 2005, 40: 17-25. 10.1086/426436.CrossRefPubMed Parent du Châtelet I, Traore Y, Gessner BD, Antignac A, Naccro B, Njanpop-Lafourcade BM, Ouedraogo MS, Tiendrebeogo SR, Varon E, Taha MK: Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing. Clin Infect Dis. 2005, 40: 17-25. 10.1086/426436.CrossRefPubMed
23.
go back to reference Yaro S, Lourd M, Traoré Y, Njanpop-Lafourcade BM, Hien A, Ouedraogo MS, Traore Y, Schouls LM, Parent du Châtelet I, Gessner BD, Clinical Group; Laboratory Group: Epidemiological and molecular characteristics of a highly lethal pneumococcal meningitis epidemic in Burkina Faso. Clin Infect Dis. 2006, 43: 693-700. 10.1086/506940.CrossRefPubMed Yaro S, Lourd M, Traoré Y, Njanpop-Lafourcade BM, Hien A, Ouedraogo MS, Traore Y, Schouls LM, Parent du Châtelet I, Gessner BD, Clinical Group; Laboratory Group: Epidemiological and molecular characteristics of a highly lethal pneumococcal meningitis epidemic in Burkina Faso. Clin Infect Dis. 2006, 43: 693-700. 10.1086/506940.CrossRefPubMed
24.
go back to reference Rose AMC, Mueller JE, Gerstl S, Njanpop-Lafourcade BM, Page AL, Nicolas P, Traoré RO, Caugant DA, Guerin PJ: Meningitis dipstick rapid test: evaluating diagnostic performance during an urban Neisseria meningitidis serogroup A outbreak, Burkina Faso, 2007. PLoS ONE. 2010, 5: e11086-10.1371/journal.pone.0011086.CrossRefPubMedPubMedCentral Rose AMC, Mueller JE, Gerstl S, Njanpop-Lafourcade BM, Page AL, Nicolas P, Traoré RO, Caugant DA, Guerin PJ: Meningitis dipstick rapid test: evaluating diagnostic performance during an urban Neisseria meningitidis serogroup A outbreak, Burkina Faso, 2007. PLoS ONE. 2010, 5: e11086-10.1371/journal.pone.0011086.CrossRefPubMedPubMedCentral
25.
go back to reference Ouedraogo RT, Njanpop-Lafourcade BM, Jaillard P, Traoré Y, Mueller JE, Aguilera JF, Dabal M, Tiendrébéogo SR, Goehde W, Da Silva A, Gessner BD, Stoeckel P: Mobile laboratory to improve response to meningitis epidemics, Burkina Faso epidemic season 2004. http://factsreports.revues.org/144 Accessed 18 Novembre, 2011 Ouedraogo RT, Njanpop-Lafourcade BM, Jaillard P, Traoré Y, Mueller JE, Aguilera JF, Dabal M, Tiendrébéogo SR, Goehde W, Da Silva A, Gessner BD, Stoeckel P: Mobile laboratory to improve response to meningitis epidemics, Burkina Faso epidemic season 2004. http://​factsreports.​revues.​org/​144 Accessed 18 Novembre, 2011
Metadata
Title
Definition and characterization of localised meningitis epidemics in Burkina Faso: a longitudinal retrospective study
Authors
Haoua Tall
Stéphane Hugonnet
Philippe Donnen
Michèle Dramaix-Wilmet
Ludovic Kambou
Frank Drabo
Judith E Mueller
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2012
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-12-2

Other articles of this Issue 1/2012

BMC Infectious Diseases 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.